FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/07/2026
Voltar para busca
Dado oficial do USPTO
GEROADX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
24/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 44
Data de depósito
10/04/2024
Data de registro
20/01/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/01/2026
Última transação
24/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
ES
Examinador
CORNWELL, ANDREA B
Unidade examinadora
M60
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording "GEROADX" with a chevron on the right side of the letter "X".
Titulares e representantes
Titulares
G. S. (pessoa física)
Representantes
Ramón Andres Urteaga PatentXL Law Firm
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations for scientific use; diagnostic preparations for use in research laboratories; diagnostic substancesother than those for medical usefor scientific research in the field of neurodegenerative diseases using the salivary biomarker lactoferrin; diagnostic kits comprising specimen receptors in the nature of microplates coated with anti-lactoferrin antibodies and diagnostic reagents for analyzing selected bacteria for purposes of quantifying salivary lactoferrin for scientific research purposes; diagnostic reagentsexcept for medical or veterinary use
Classe 5
Diagnostic preparations for medical use; diagnostic substances for medical use; medical diagnostic test strips for saliva analysis for the early detection of Alzheimer's Disease and Mild Cognitive Impairment associated with Alzheimer's Disease; diagnostic agents for medical use; diagnostic products for medical usemedical diagnostic reagents and immunoassay kits comprising diagnostic agentspreparations and substances for in vitro quantification of salivary lactoferrin; diagnostic testing materials for medical usediagnostic test reagents and antibody-coated microplates for in vitro testing for medical use; diagnostic preparations for medical use in medical laboratories; products for medical diagnosticsmedical diagnostic reagentsimmunoassay kits comprising diagnostic agentspreparations and substancesdiagnostic preparations for the in vitro detection of the salivary biomarker lactoferrinassociated with Alzheimer's Disease and Mild Cognitive Impairment associated with Alzheimer's Disease; diagnostic reagents for medical use; chemical diagnostic reagents for medical use
Classe 10
Automatic saliva biomarker analyzers for medical diagnostic purposes; medical immunochemical diagnostic apparatus for medical use; detector apparatus for medical use in diagnosis namelydiagnostic apparatus for the detection and quantification of salivary lactoferrin as a biomarker associated with Alzheimer's Disease; diagnostic apparatus for measuring for medical useimmunochemical diagnostic testing apparatus for measuring salivary lactoferrin levels as an aid in the early detection of Alzheimer's Disease
Classe 44
Medical analyses for the diagnosis and treatment of people; medical diagnostic servicesincluding medical diagnostic testing and analysis; medical services for the diagnosis of diseases in the human body
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
FIMP
FINAL DISPOSITION PROCESSED
24/07/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
20/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/12/2025
GPNX
NOTIFICATION PROCESSED BY IB
11/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2025
PUBO
PUBLISHED FOR OPPOSITION
02/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/11/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/10/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
31/10/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/05/2025
GNFR
FINAL REFUSAL E-MAILED
01/05/2025
CNFR
FINAL REFUSAL WRITTEN
01/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2025
RFNT
REFUSAL PROCESSED BY IB
23/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2024
RFRR
REFUSAL PROCESSED BY MPU
07/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/10/2024
CNRT
NON-FINAL ACTION WRITTEN
30/10/2024
DOCK
ASSIGNED TO EXAMINER
23/10/2024
MAFR
APPLICATION FILING RECEIPT MAILED
26/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/07/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/07/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GEROADX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.